{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:27:03Z","timestamp":1790486823060,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007083","name":"Orion Research Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.brainresbull.2026.111872","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:14:17Z","timestamp":1775315657000},"page":"111872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Characterisation of a patient-derived iPSC-based model for studying the blood-brain barrier in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"239","author":[{"given":"Sylvia","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Danz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooseppi","family":"Hyv\u00e4rinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja M.","family":"Kanninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Gynther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-389X","authenticated-orcid":false,"given":"Elena","family":"Puris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2026.111872_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2026.111872_bib2","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1074\/mcp.E113.031658","article-title":"Western blots versus selected reaction monitoring assays: time to turn the tables?","volume":"12","author":"Aebersold","year":"2013","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.brainresbull.2026.111872_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216288","article-title":"Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of human blood-brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.brainresbull.2026.111872_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Alzheimer's","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.brainresbull.2026.111872_bib6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.stemcr.2017.02.021","article-title":"Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem Cells","volume":"8","author":"Appelt-Menzel","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.brainresbull.2026.111872_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cpsc.122","article-title":"Human iPSC-derived blood-brain barrier models: valuable tools for preclinical drug discovery and development?","volume":"55","author":"Appelt-Menzel","year":"2020","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejpb.2022.02.017","article-title":"Re-evaluation of the hCMEC\/D3 based in vitro BBB model for ABC transporter studies","volume":"173","author":"Balzer","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.brainresbull.2026.111872_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"2018","journal-title":"J. R. Stat. Soc. Ser. B (Methodol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.brainresbull.2026.111872_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.14336\/AD.2017.0112","article-title":"Cerebral microvascular accumulation of tau oligomers in alzheimer's disease and related tauopathies","volume":"8","author":"Castillo-Carranza","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.brainresbull.2026.111872_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/360674a0","article-title":"Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons","volume":"360","author":"Chen","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2026.111872_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1212\/WNL.55.6.763","article-title":"A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease","volume":"55","author":"Crawford","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2026.111872_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040737","article-title":"Experimental Comparison of Primary and hiPS-Based In Vitro Blood-Brain Barrier Models for Pharmacological Research","volume":"14","author":"Danz","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.brainresbull.2026.111872_bib15","article-title":"circRNAs as Epigenetic Regulators of Integrity in Blood-Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis","volume":"13","author":"D'Aversa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.brainresbull.2026.111872_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.brainresbull.2026.111872_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040994","article-title":"Establishment of an in vitro human blood-brain barrier model derived from induced pluripotent stem cells and comparison to a porcine cell-based system","volume":"9","author":"Di Marco","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.brainresbull.2026.111872_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-2012-112189","article-title":"ABCG2- and ABCG4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood-brain barrier","volume":"30","author":"Do","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2026.111872_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.brainresbull.2026.111872_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14543","article-title":"Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's-related phenotypes","volume":"21","author":"Feng","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.brainresbull.2026.111872_bib21","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1021\/acs.jproteome.2c00145","article-title":"Protein Contaminants Matter: Building Universal Protein Contaminant Libraries for DDA and DIA Proteomics","volume":"21","author":"Frankenfield","year":"2022","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.brainresbull.2026.111872_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2026.111872_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12987-023-00424-5","article-title":"The CLDN5 gene at the blood-brain barrier in health and disease","volume":"20","author":"Hashimoto","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.brainresbull.2026.111872_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/jnc.13389","article-title":"vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparalpha) at the blood-brain barrier","volume":"135","author":"Hoque","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2026.111872_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neurobiolaging.2013.11.004","article-title":"Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease","volume":"35","author":"Huang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2026.111872_bib26","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/s41467-023-37840-y","article-title":"Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy","volume":"14","author":"Hussong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainresbull.2026.111872_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.14336\/AD.2019.0519","article-title":"Alteration in the Function and Expression of SLC and ABC Transporters in the Neurovascular Unit in Alzheimer's Disease and the Clinical Significance","volume":"11","author":"Jia","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.brainresbull.2026.111872_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-8993(92)91193-I","article-title":"Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease","volume":"585","author":"Kalaria","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.brainresbull.2026.111872_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111994","article-title":"IQGAP2 regulates blood-brain barrier immune dynamics","volume":"28","author":"Katdare","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.brainresbull.2026.111872_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12987-019-0139-4","article-title":"The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model","volume":"16","author":"Katt","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.brainresbull.2026.111872_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3988\/jcn.2023.0095","article-title":"Role of A-Kinase Anchoring Protein 12 in the Central Nervous System","volume":"19","author":"Kimura","year":"2023","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib33","doi-asserted-by":"crossref","unstructured":"Kistner, F., Grossmann, J.L., Sinn, L.R., Demichev, V., 2023. QuantUMS: uncertainty minimisation enables confident quantification in proteomics. 2023.2006.2020.545604.","DOI":"10.1101\/2023.06.20.545604"},{"key":"10.1016\/j.brainresbull.2026.111872_bib34","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.6102-11.2012","article-title":"Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling","volume":"32","author":"Kook","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib35","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.23993","article-title":"Disruption of blood-brain barrier in Alzheimer disease pathogenesis","volume":"1","author":"Kook","year":"2013","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.brainresbull.2026.111872_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10571-009-9358-6","article-title":"New age of neuroproteomics in Alzheimer's disease research","volume":"29","author":"Kovacech","year":"2009","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib38","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/alz.12104","article-title":"Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease","volume":"16","author":"Liu","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.brainresbull.2026.111872_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1755-5949.2012.00340.x","article-title":"Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances","volume":"18","author":"Liu","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.brainresbull.2026.111872_bib40","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.18632\/aging.101615","article-title":"Transferrin is responsible for mediating the effects of iron ions on the regulation of anterior pharynx-defective-1alpha\/beta and Presenilin 1 expression via PGE(2) and PGD(2) at the early stage of Alzheimer's Disease","volume":"10","author":"Lu","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.brainresbull.2026.111872_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","article-title":"The revitalized tau hypothesis on Alzheimer's disease","volume":"41","author":"Maccioni","year":"2010","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.brainresbull.2026.111872_bib42","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.brainresbull.2026.111872_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.52","article-title":"d-serine levels in Alzheimer's disease: implications for novel biomarker development","volume":"5","author":"Madeira","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainresbull.2026.111872_bib44","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.R116.760215","article-title":"The Translational Significance of the Neurovascular Unit","volume":"292","author":"McConnell","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2026.111872_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570045","article-title":"Tau Protein and Its Role in Blood-Brain Barrier Dysfunction","volume":"13","author":"Michalicova","year":"2020","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.brainresbull.2026.111872_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems","volume":"20","author":"Moos","year":"2000","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib48","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.brainresbull.2026.111872_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12987-023-00501-9","article-title":"Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line","volume":"20","author":"Ozgur","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.brainresbull.2026.111872_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acel.12530","article-title":"Annexin A1 restores Abeta(1-42) -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway","volume":"16","author":"Park","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.brainresbull.2026.111872_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122864","article-title":"Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction","volume":"314","author":"Pavlou","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2026.111872_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-170639","article-title":"ABC Transporters Are Key Players in Alzheimer's Disease","volume":"61","author":"Pereira","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2026.111872_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070948","article-title":"Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer's Disease","volume":"16","author":"Petralla","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.brainresbull.2026.111872_bib54","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-03990-3","article-title":"Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer's Disease Is Associated with Activation of HIF-1 Signaling Pathway","author":"Petralla","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib55","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pmic.200800503","article-title":"Actin, gelsolin and filamin-A are dynamic actors in the cytoskeleton remodelling contributing to the blood brain barrier phenotype","volume":"9","author":"Pottiez","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.brainresbull.2026.111872_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-022-03241-x","article-title":"Targeting transporters for drug delivery to the brain: can we do better?","author":"Puris","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.brainresbull.2026.111872_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105741","article-title":"Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model","volume":"169","author":"Puris","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2026.111872_bib58","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s12035-022-03111-y","article-title":"Protein expression of amino acid transporters is altered in isolated cerebral microvessels of 5xFAD mouse model of alzheimer's disease","volume":"60","author":"Puris","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.brainresbull.2026.111872_bib60","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1523\/JNEUROSCI.3836-12.2013","article-title":"Neuronal D-serine and glycine release via the Asc-1 transporter regulates NMDA receptor-dependent synaptic activity","volume":"33","author":"Rosenberg","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239078","article-title":"AKAP12 Supports Blood-Brain Barrier Integrity against Ischemic Stroke","volume":"21","author":"Seo","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib62","article-title":"Blood-Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease","volume":"6","author":"Shin","year":"2019","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.brainresbull.2026.111872_bib63","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1154641","article-title":"Junctional proteins of the blood-brain barrier: New insights into function and dysfunction","volume":"4","author":"Stamatovic","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.brainresbull.2026.111872_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymeth.2015.10.016","article-title":"Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells","volume":"101","author":"Stebbins","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.brainresbull.2026.111872_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102034","article-title":"The EBiSC iPSC bank for disease studies","volume":"49","author":"Steeg","year":"2020","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.brainresbull.2026.111872_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106864","article-title":"Vascular models of Alzheimer's disease: an overview of recent in vitro models of the blood-brain barrier","volume":"208","author":"Takeuchi","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2026.111872_bib67","unstructured":"Team, R.C., 2025. R: A language and environment for statistical computing., R Foundation for Statistical Computing, Vienna, Austria."},{"key":"10.1016\/j.brainresbull.2026.111872_bib68","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the Universal Protein Knowledgebase in 2023","volume":"51","author":"UniProt","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.brainresbull.2026.111872_bib69","article-title":"Cystatin C Shifts APP Processing from Amyloid-beta Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2026.111872_bib70","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1007\/s12035-023-03245-7","article-title":"The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis","volume":"60","author":"Wu","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2026.111872_bib71","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","article-title":"ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides","volume":"29","author":"Xiong","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib72","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/awz011","article-title":"Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression","volume":"142","author":"Yamazaki","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.brainresbull.2026.111872_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2045-8118-10-13","article-title":"Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging","volume":"10","author":"Zhang","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.brainresbull.2026.111872_bib74","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","article-title":"Dysfunction of NMDA receptors in Alzheimer's disease","volume":"37","author":"Zhang","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2026.111872_bib75","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and Dysfunction of the Blood-Brain Barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2026.111872_bib76","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.18632\/aging.204029","article-title":"Claudin-5 relieves cognitive decline in Alzheimer's disease mice through suppression of inhibitory GABAergic neurotransmission","volume":"14","author":"Zhu","year":"2022","journal-title":"Aging"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923026001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923026001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:43:28Z","timestamp":1777970608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923026001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":76,"alternative-id":["S0361923026001589"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2026.111872","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation of a patient-derived iPSC-based model for studying the blood-brain barrier in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2026.111872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111872"}}